"Application of the ultra micro analytical system (SUMA) technology for the detection of urinary hCG in antidoping control". Issue 6 (2nd November 2018)

• Record Type: Journal Article
• Authors: Martinez_Brito, Dayamin; Bueno_Fis, Elizabeth; Fiallo_Fernandez, Taimi; Torres_Castellanos, Mirta; Correa_Vidal, M. Teresa; Montes De Oca_Porto, Rodny
• Is Part Of: Journal of immunoassay & immunochemistry. Volume 39:Issue 6(2018)
• Page Start: 672
• Page End: 686
• Publication Date: 2018-11-02
• Subjects: SUMA -- chorionic gonadotrophin hormone -- antidoping control -- immunoassays -- validation -- Kappa Index; Immunoassay -- Periodicals; Immunochemistry -- Periodicals; Immunoassay -- periodicals; Immunochemistry -- periodicals; 571.96405
• DOI: 10.1080/15321819.2018.1531020
• Languages: English
• ISSNs: 1532-1819

Abstract

ABSTRACT: The Ultra Micro Analytical System (SUMA) is an ELISA-based analytical platform, developed andmanufactured by the Cuban Immunoassay Center (IC), which is primarily used in clinical medicine applications. In this article, we describe the validation of the UMELISA HCG kits, which are based on SUMA, as a pre-screening procedure for the detection of human Chorionic Gonadotrophin (hCG) in urine for anti-doping purposes. Validation of assay performance parameters showed satisfactory results, in accordance with the criteria established by the World Anti-Doping Agency (WADA): intra-assay repeatability (6.7–9.7%), inter-assay reproducibility (7.8–10.5%), accuracy (91–98%), limit of detection (2.7 IU/L), and linearity. Relative sensitivity and specificity and Predictive Positive and Negative Values were used to evaluate the Efficacy showing a value of 97.6%. A Kappa Index analysis was applied to check agreement with the commercially available, reference assay COBASe411 (Roche), which is often applied in WADA-accredited anti-doping laboratories for measurement of intact (heterodimeric) hCG in urine. UMELISA HCG kits are considered as fit for anti-doping control purposes.